health · source
STAT News on WeSearch
Recent health headlines from STAT News.
STAT NEWS
STAT+: BioNTech and Pfizer tout bispecifics data, and Pazdur sees silver lining at FDA
STAT NEWS
STAT+: China competition, ‘destruction’ at FDA gives agency chance to restructure, Rick Pazdur says
STAT
STAT+: Revolution Medicines starts shipping experimental pancreatic cancer drug
STAT NEWS
STAT+: As Ebola outbreak grows, Trump administration veers from previous government playbook
STAT NEWS
STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer
STAT NEWS
STAT+: Allogene CEO David Chang stepping down
STAT NEWS
Which vaccines will curb the Ebola outbreak? WHO debates
STAT NEWS
STAT+: Up and down the ladder: The latest comings and goings
STAT
Opinion: I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’
STAT
STAT+: The woman behind the world’s biggest longevity competition
STAT
STAT+: Biotech veteran Jeremey Levin on why the industry’s future is secure, but American leadership is at risk
STAT
An ASCO preview: What to watch for at cancer research’s big meeting
STAT NEWS
STAT+: Heart patch engineered from stem cells revved up weakened hearts
STAT NEWS
Kailera’s own ‘triple-G’ drug also looks very powerful
STAT
STAT+: Pharmalittle: We’re reading about an AstraZeneca breast cancer pill, an ADAP deal in Florida, and more
STAT
Trump says latest medical exam went ‘PERFECTLY’
STAT NEWS
Opinion: Sen. Dick Durbin: Trump is letting Big Tobacco target children
STAT NEWS
Opinion: The patients demanding unvaccinated blood transfusions
STAT NEWS
STAT+: How Stanford patients help expose ‘fault lines’ in health AI adoption
STAT NEWS
‘Are we just going to give up and die like every other generation?’
STAT NEWS
Opinion: It’s the end of science as we know it, and I feel fine
STAT NEWS
Trump is seeing doctors for his annual physical. What the public finds out is up to him
STAT NEWS
What do early data from Utah’s Doctronic AI pilot show?
STAT
Ebola outbreak continues to worsen, with new collateral risks for girls and women
STAT
STAT+: Pharmalittle: We’re reading about a Lilly gene therapy for cholesterol, three new Lilly deals, and more
STAT NEWS
STAT+: Eli Lilly to buy three small vaccine developers
STAT NEWS
STAT+: How Kyle Diamantas defied expectations as he rose to lead the FDA
STAT NEWS
Opinion: The Ebola outbreak will lead to devastating violence against women and girls
STAT NEWS
Opinion: 8 former CDC directors: Reform PEPFAR, don’t dismantle it
STAT NEWS
STAT+: An AI biotech CEO sets the record straight on AI drug development hype
STAT NEWS
Opinion: The innovation trap: How pharma weaponizes a word to extend monopolies
STAT
STAT+: Eli Lilly says Verve’s gene editor lowers cholesterol levels in early study
STAT NEWS
Opinion: How the perimenopause movement is hurting women
STAT NEWS
STAT+: Congress slashed Medicaid funding to providers. The Trump administration wants to cut even further
STAT
A CDC page on mpox caught in political crosshairs
STAT
STAT+: Pharmalittle: We’re reading about a Parkinson’s drug setback, a Merck lung cancer therapy, and more
STAT NEWS
STAT+: Longevity startup Retro Biosciences says latest fundraising values it at $1.8 billion
STAT NEWS
A federal office of men’s health has never been closer, yet it’s likely still years away
STAT NEWS
STAT+: Genentech is soliciting research that can be used to blunt pharma reforms in Washington
STAT NEWS
Opinion: Check-in and intake at the doctor’s office are perfect for AI
STAT NEWS
Opinion: The seed oil panic is hurting my cardiac patients
STAT
Mass General Brigham says it is saving more lives. Some doctors aren’t so sure.
STAT
STAT+: Closely watched experimental Parkinson’s drug fails key clinical trial
STAT NEWS
Guarding biotech from China and big bets in longevity
STAT
STAT+: Immunovant shares surge on arthritis trial data
STAT
STAT+: Acting head of NIH’s infectious disease institute reported to have stepped down
STAT
STAT+: Elevance executive ordered to testify in Medicare Advantage fraud case
STAT
Live: Senate committee questions NIH director on 2027 budget
STAT
STAT+: Pharmalittle: We’re reading about a Lilly obesity drug trial, statistics for an Alzheimer’s drug, and more
STAT